HOME STORY OF OUR FIRM SEARCH
ASBESTOS DRUGS POLLUTANTS ACCIDENTS MALPRACTICE
English En Français

FREE LEGAL REVIEW

First Name
Last Name
Home Phone
Work Phone
City and State
Email
Were you diagnosed with Asbestosis? Yes
Were you diagnosed with lung cancer? Yes
Were you diagnosed with Mesothelioma? yes
What is your date of diagnosis?
Additional Comments
Best time to call?

Clinical Trials for Mesothelioma Patients: Cisplatin, Imatinib Mesylate, and Pemetrexed Contact Information

Read more here to obtain contact information for the facilities participating in the current clinical trial being conducted to study the effects of Cisplatin, Imatinib Mesylate, and Pemetrexed for patients who have been diagnosed with mesothelioma. Please note: this information is provided by Weitz & Luxenberg for informational purposes only.

Locations:
U.T.M.D. Anderson Cancer Center
Houston, Texas, United States, 77030
Contact: Anne S. Tsao, MD
713-792-6363

Courtesy of ClinicalTrials.gov, a service of the U.S. National Institutes of Health

Other helpful links:

Asbestos Asbestos
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney
Mesothelioma Mesothelioma Home Page
head Mesothelioma: An Overview
kleio The Clock Is Ticking
asbestos Our Toughest Cases
head Diagnosis
treatment Symptoms, Stages, Treatment
kleio Latest News
New York Numbers
Asbestos
Real Stories


Mesothelioma
Mesothelioma Treatments
Treatment
Clinical trials for mesothelioma
IN THIS SECTION
Imatinib Mesylate trial for mesothelioma patients
Outcomes of Imatinib against mesothelioma cancer
Recruitment data to test Imatinib on mesothelioma
Inclusion standard in Imatinib mesothelioma trial
Exclusion standard in Imatinib mesothelioma trial
Contact info for Imatinib mesothelioma study

Mesothelioma Lawyer

Asbestos Lawyer

Mesothelioma Attorney

Asbestos Attorney

For legal help anywhere in the U.S. call:

1 - 800 - 476 - 6070

Prior results do not guarantee a similar outcome.

ATTORNEY ADVERTISING
see also:

Inclusion standard in Imatinib mesothelioma trial Inclusion criteria to treat mesothelioma patients with Imatinib
Patient inclusion criteria for Imatinib mesothelioma clinical trial

Exclusion standard in Imatinib mesothelioma trial Exclusion criteria to treat mesothelioma patients with Imatinib
Patient exclusion criteria for Imatinib mesothelioma clinical trial

Current Imatinib therapy for mesothelioma patients Current clinical trial of Imatinib therapy for mesothelioma patients
Imatinib may inhibit cancer cell growth in current mesothelioma test